Vaccines to prevent coccidioidomycosis: a gene-deletion mutant of coccidioides posadasii as a viable candidate for human trials

HIGHLIGHTS

• who: John N. Galgiani et al. from the Valley Fever Center for Excellence, University of Arizona College of Medicine-Tucson, Tucson, AZ, USA have published the research work: Vaccines to Prevent Coccidioidomycosis: A Gene-Deletion Mutant of Coccidioides Posadasii as a Viable Candidate for Human Trials, in the Journal: (JOURNAL) of 17/03/2021
• what: This study shows the investigative efficacy of the ∆cps1 to mitigate infection in a These encouraging findings led the team, invaccine partnership with Anivive target species, which is also a larger animal model that has a rate and range of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.